LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
LENSAR, Inc.NASDAQ: LNSR
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation outflow shrinks to $0
Q1 FY2026 stock-based compensation was $0, compared with $654K a year earlier. Trailing-twelve-month stock-based compensation was $2.49M. Over 3 fiscal years it compounded at -22.0% a year.
Context
- Stock-based compensation amounted to 5.4% of revenue in FY2025, up 0.4 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $622.25K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 3.14M USD
- Year-over-year change
- +17.9%
- 4-year CAGR
- -17.7%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.14M | +17.9% |
| FY2024 | 2024-12-31 | 2.67M | -51.9% |
| FY2023 | 2023-12-31 | 5.54M | -16.2% |
| FY2022 | 2022-12-31 | 6.61M | -3.7% |
| FY2021 | 2021-12-31 | 6.87M | — |
Stock-Based Compensation vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 stock-based compensation of $2.49M is the 9th largest of the 10 companies compared; the peer median is $5.99M.
- Its year-over-year change of -6.7% is the 8th highest of 10, against a peer median of +11.8%.
- Stock-based compensation amounts to 4.3% of revenue for LNSR, versus a peer median of 17.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $13.86M | +11.8% | -11.0% | 11.9% | |
| LTM Mar 2026 | $11.18M | +38.7% | -10.1% | 10.4% | |
| LTM Mar 2026 | $9.98M | +67.1% | +191.7% | 22.2% | |
| LTM Mar 2026 | $6.49M | -5.6% | +3.2% | — | |
| LTM Mar 2026 | $5.99M | +19.7% | +10.2% | 1140.6% | |
| LTM Mar 2026 | $5.55M | +98.0% | +9.0% | 29.4% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $4.48M | -15.1% | +38.4% | 241.9% |
| LTM Mar 2026 | $4.21M | +10.0% | +0.1% | 12.3% | |
| LTM Mar 2026 | $2.49M | -6.7% | -22.0% | 4.3% | |
| LTM Mar 2026 | $706K | -76.8% | — | 2.2% | |
| Peer median (excluding LNSR) | $5.99M | +11.8% | +6.1% | 17.2% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Deferred Income Tax | 527K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Change in Working Capital | (42K) | (5.58M) | (7.78M) | (3.04M) | 1.1M |
| Accounts Receivables | (2.65M) | (1.44M) | 1.08M | (2.1M) | 289K |
| Inventory | 2.33M | (6.89M) | (7.46M) | (4.9M) | (13.9M) |
| Accounts Payables | 213K | 2.73M | (1.42M) | 1.96M | 12.99M |
| Other Working Capital | 66K | 23K | 23K | 2M | 1.72M |
| Other Non-Cash Items | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Operating Cash Flow | (8.97M) | (14.86M) | (9.66M) | (2.28M) | (14.83M) |
| Capital Expenditures | (354K) | (115K) | (236K) | (156K) | (83K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (3.92M) | (10.25M) | (11.88M) |
| Sales of Investments | 0 | 0 | 0 | 8.24M | 13.25M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (354K) | (115K) | (4.16M) | (2.16M) | 1.28M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 361K | 408K | 0 | 58K | 258K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.4M) | 5.88M | 20K | 10M |
| Financing Cash Flow | 361K | (1.99M) | 19.76M | 78K | 10.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.96M) | (16.96M) | 5.95M | (4.36M) | (3.29M) |
| Free Cash Flow | (9.32M) | (14.97M) | (9.9M) | (2.43M) | (14.91M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.